Decker Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Decker Wealth Management's GILD Position: Q3 2026 in Review
Decker Wealth Management reduced its Gilead Sciences (GILD) stake by 13% in Q3 2026, selling an estimated $50.2K and leaving 2,467 shares worth $368K. The position accounts for 0.07% of the portfolio, ranked #95.
Decker Wealth Management first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. The position peaked at $394K in Q1 2026. 2,355 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Decker Wealth Management held 2,467 shares of Gilead Sciences worth $368K as of Q3 2026.
- Decker Wealth Management sold 358 Gilead Sciences shares in Q3 2026, an estimated $50.2K.
- Gilead Sciences made up 0.07% of Decker Wealth Management's portfolio in Q3 2026, its #95 holding.
- Decker Wealth Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
- Decker Wealth Management's Gilead Sciences position peaked at $394K in Q1 2026.
- 2,355 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Decker Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.